Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022

Abstract Background Various regulatory authorities are experiencing backlogs of applications which result in delayed access to medicines for patients. The objective of this study is to critically assess the registration process utilised by SAHPRA between 2011 and 2022 and determine the fundamental r...

Full description

Bibliographic Details
Main Authors: Lerato Moeti, Madira Litedu, Jacques Joubert
Format: Article
Language:English
Published: Taylor & Francis Group 2023-03-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:https://doi.org/10.1186/s40545-023-00537-0